Do you burn to lose weight?
Dr. Daniel Rosen, a New York City-based surgeon and weight loss doctor, did the following on TikTok. Share rare complications He observed patients using GLP-1 drugs.
“What I’ve been seeing in my patients lately, a very small but legitimate number of them, is allodynia,” Rosen said.@dranielrosen) told his 70,000 followers.
Rosen explained that allodynia is a type of neuralgia caused by things that aren’t supposed to cause discomfort. Examples include pain or irritation when combing your hair or putting on your shirt.
There are three types of allodynia.
- mechanical: Pain occurs when an object comes into contact with the skin.
- static: Pain caused by light touch or pressure on the skin
- heat: Pain is caused by slight changes in temperature, such as when moving from indoors to outdoors.
“Allodynia is a sensation in your skin that doesn’t match the stimulus being applied. The idea is that just the wind blowing against your skin, or your clothes rubbing against your skin, can cause your skin to feel burning or painful.”
Rosen said patients are complaining of pain in their shoulders, thighs and backs. He noted that side effects are listed in the literature for some GLP-1 drugs, but not for Zepbound (tirzepatide).
“I think in general, GLP-1 drugs somehow sensitize the skin nerves, causing a reaction where the skin becomes hypersensitive to stimulation, causing sensations in the brain like pain, burning, tingling, and itching. “
Rosen argued that symptoms could be alleviated by lowering the dose and then gradually increasing it.
“I don’t think it’s much of a concern unless it becomes so onerous that you sacrifice the positive effects by stopping the drug.”
And its long list of positive benefits extends beyond weight loss. GLP-1 researchers have tested the drug’s superpowers against chronic diseases such as colorectal cancer, osteoarthritis, drug and alcohol addiction, and brain disorders.
On the contrary, in addition to neuralgia, users of these same drugs experience side effects such as erectile dysfunction, changes in personality, unpleasant gastrointestinal problems, increased reckless behavior, and the frightening saggy reality of Ozempic’s buttocks and breasts. is reported.
Still, for some, sacrificing breathing for combustion may be worth it.
On December 20, the FDA announced that it has approved Zepbound for the treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults.
